All Research Articles

Home Browse Articles
1-20 of 52 ARTICLES
Previous Next
 in 
https://doi.org/10.12688/f1000research.26058.1
Review metrics
Interleukin-6 signalling in health and disease
[version 1; peer review: 3 approved]
Stefan Rose-John
Peer Reviewers Elke Roeb; Hana Algül; Jacqueline Bromberg
  • Funder
  • Deutsche Forschungsgemeinschaft
PUBLISHED 20 Aug 2020
https://doi.org/10.12688/f1000research.19811.1
Review metrics
Pharmacological treatment and current controversies in COPD
[version 1; peer review: 3 approved]
Mario Cazzola, Paola Rogliani, Daiana Stolz, Maria Gabriella Matera
Peer Reviewers Reynold Panettieri; omar usmani; Masakazu Ichinose
PUBLISHED 29 Aug 2019
https://doi.org/10.12688/f1000research.18701.1
Review metrics
Recent advances in celiac disease and refractory celiac disease
[version 1; peer review: 2 approved]
Georgia Malamut, Sascha Cording, Nadine Cerf-Bensussan
Peer Reviewers Alessio Fasano; Armin Alaedini
  • Funders
  • la Fondation Princesse Grace
  • Association pour la Recherche Contre le Cancer
  • Agence Nationale pour la Recherche (ANR)
  • French Association of patients intolerant to gluten (AFDIAG)
PUBLISHED 26 Jun 2019
https://doi.org/10.12688/f1000research.18831.1
Review metrics
IL-1 in osteoarthritis: time for a critical review of the literature
[version 1; peer review: 2 approved]
Tonia L. Vincent
Peer Reviewers Tariq M. Haqqi; Charles J. Malemud
  • Funder
  • Versus Arthritis
PUBLISHED 21 Jun 2019
https://doi.org/10.12688/f1000research.17479.1
Review metrics
40 years of the human T-cell leukemia virus: past, present, and future
[version 1; peer review: 2 approved]
Yutaka Tagaya, Masao Matsuoka, Robert Gallo
Peer Reviewers Anne Van den Broeke; Roberto S Accolla
PUBLISHED 28 Feb 2019
https://doi.org/10.12688/f1000research.17023.1
Review metrics
Tumour necrosis factor signalling in health and disease
[version 1; peer review: 2 approved]
Jonathan Holbrook, Samuel Lara-Reyna, Heledd Jarosz-Griffiths, Michael F. McDermott
Peer Reviewers Rudi Beyaert; Lisa Sedger
  • Funders
  • Leeds Institute of Medical Research (LIMR)
  • Consejo Nacional de Ciencia y Tecnología (CONACyT)
  • Cystic Fibrosis Trust
PUBLISHED 28 Jan 2019
https://doi.org/10.12688/f1000research.17267.1
Systematic Review metrics
A systematic review and critical evaluation of inflammatory cytokine associations in hidradenitis suppurativa
[version 1; peer review: 2 approved, 1 approved with reservations]
John W. Frew, Jason E. Hawkes, James G. Krueger
Peer Reviewers Barbara Horváth and Lisette Prens; Aude Nassif; Evangelos J. Giamarellos-Bourboulis
  • Funders
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
PUBLISHED 13 Dec 2018
https://doi.org/10.12688/f1000research.16222.1
Review metrics
Recent advances in understanding chronic rhinosinusitis endotypes
[version 1; peer review: 2 approved]
Eric F. Succar, Justin H. Turner
Peer Reviewers Murugappan Ramanathan Jr; Zheng Liu
  • Funders
  • National Institute of Allergy and Infectious Diseases
  • National Center for Advancing Translational Sciences
  • National Institute of Deafness and Communication Disorders
PUBLISHED 07 Dec 2018
https://doi.org/10.12688/f1000research.15695.1
Review metrics
Role of alarmin cytokines and microRNAs in the host-schistosome interaction
[version 1; peer review: 3 approved]
Xing He, Weiqing Pan
Peer Reviewers Geoffrey N Gobert; Hui Fen Dong; Bolaji Thomas
  • Funder
  • National Natural Science Foundation of China
PUBLISHED 28 Sep 2018
https://doi.org/10.12688/f1000research.15337.1
Review metrics
Recent advances in understanding rhinovirus immunity
[version 1; peer review: 4 approved]
Spyridon Makris, Sebastian Johnston
Peer Reviewers Zhao-jun Duan; Reena Ghidyal; Ville Peltola; Larry J Anderson
PUBLISHED 24 Sep 2018
https://doi.org/10.12688/f1000research.14956.1
Review metrics
Recent advances in ankylosing spondylitis: understanding the disease and management
[version 1; peer review: 2 approved]
Leticia Garcia-Montoya, Hanna Gul, Paul Emery
Peer Reviewers Nigil Haroon; Michael Ward
PUBLISHED 21 Sep 2018
https://doi.org/10.12688/f1000research.13941.1
Review metrics
Recent advances in the management of systemic lupus erythematosus
[version 1; peer review: 2 approved]
Savino Sciascia, Massimo Radin, Dario Roccatello, Giovanni Sanna, Maria Laura Bertolaccini
Peer Reviewers Mandana Nikpour; Christian M. Hedrich
PUBLISHED 29 Jun 2018
https://doi.org/10.12688/f1000research.14238.1
Review metrics
New insights into the immunomodulatory properties of poxvirus cytokine decoy receptors at the cell surface
[version 1; peer review: 2 approved]
Bruno Hernaez, Antonio Alcami
Peer Reviewers María Magdalena Gherardi; Gareth Brady
  • Funder
  • Spanish Ministry of Economy and Competitiveness and European Union (European Regional Development’s Funds, FEDER)
PUBLISHED 11 Jun 2018
https://doi.org/10.12688/f1000research.13170.1
Review metrics
Recent advances in biologic therapy of asthma and the role in therapy of chronic rhinosinusitis
[version 1; peer review: 2 approved]
Rohit Divekar, Devyani Lal
Peer Reviewers Spencer Payne; Ahmad Sedaghat
PUBLISHED 29 Mar 2018
https://doi.org/10.12688/f1000research.13362.1
Review metrics
Recent advances in understanding West Nile virus host immunity and viral pathogenesis
[version 1; peer review: 2 approved]
Huanle Luo, Tian Wang
Peer Reviewers Aaron C Brault; Helle Bielefeldt-Ohmann
  • Funder
  • NIH/NIAID
PUBLISHED 19 Mar 2018
https://doi.org/10.12688/f1000research.13446.1
Review metrics
Immune regulation by Tim-3
[version 1; peer review: 2 approved]
Hridesh Banerjee, Lawrence P. Kane
Peer Reviewers Mario A. Ostrowski; MeiRong Du
  • Funder
  • National Institutes of Health
PUBLISHED 14 Mar 2018
https://doi.org/10.12688/f1000research.13020.1
Review metrics
Update on regulation and effector functions of Th17 cells
[version 1; peer review: 3 approved]
Ivy Sandquist, Jay Kolls
Peer Reviewers Stuart G Tangye; Richard Flavell; Casey T. Weaver
  • Funder
  • National Heart, Lung, and Blood Institute
PUBLISHED 19 Feb 2018
https://doi.org/10.12688/f1000research.12787.1
Review metrics
New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor
[version 1; peer review: 2 approved]
Terry J Smith
Peer Reviewers Jack Wall; Willem Dik
  • Funders
  • Bell Charitable Foundation
  • National Eye Institute
  • Research to Prevent Blindness
  • National Institutes of Health
PUBLISHED 01 Feb 2018
https://doi.org/10.12688/f1000research.13167.1
Review metrics
JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders
[version 1; peer review: 2 approved]
William Vainchenker, Emilie Leroy, Laure Gilles, Caroline Marty, Isabelle Plo, Stefan N. Constantinescu
Peer Reviewers Ann Mullally; Srdan Verstovsek
  • Funders
  • Institut National du Cancer
  • MPN Research Foundation
  • Ligue Nationale Contre le Cancer
  • Institut National de la Santé et de la Recherche Médicale (Inserm)
PUBLISHED 17 Jan 2018
https://doi.org/10.12688/f1000research.11671.1
Review metrics
Senescence and tumor suppression
[version 1; peer review: 2 approved]
Philip Hinds, Jodie Pietruska
Peer Reviewers Judith Campisi; Guangyong Peng
PUBLISHED 11 Dec 2017
1-20 of 52 ARTICLES
Previous Next
PUBLISH YOUR RESEARCH
Articles
We publish a wide range of article types in science, engineering, medicine, social sciences and humanities, with no editorial biases.
SUBMIT AN ARTICLE
See guidelines and policies.
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.
Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.